See more : UV Germi SA (ALUVI.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Global Medical REIT Inc. (GMRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Medical REIT Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- SMN Corporation (6185.T) Income Statement Analysis – Financial Results
- Byrna Technologies Inc. (BYRN) Income Statement Analysis – Financial Results
- Crayon Group Holding ASA (CRAYF) Income Statement Analysis – Financial Results
- Helios Energy Limited (HE8.AX) Income Statement Analysis – Financial Results
- Royal Financial, Inc. (RYFL) Income Statement Analysis – Financial Results
Global Medical REIT Inc. (GMRE)
About Global Medical REIT Inc.
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 140.93M | 137.28M | 115.94M | 93.73M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380.41K | 0.00 | 0.00 |
Cost of Revenue | 86.22M | 25.19M | 15.49M | 10.87M | 5.96M | 3.72M | 1.86M | 1.43M | 1.02M | 360.00K | 0.00 | 0.00 |
Gross Profit | 54.72M | 112.10M | 100.45M | 82.86M | 64.77M | 49.47M | 28.36M | 6.65M | 1.04M | 20.41K | 0.00 | 0.00 |
Gross Profit Ratio | 38.82% | 81.65% | 86.64% | 88.41% | 91.58% | 93.01% | 93.85% | 82.25% | 50.54% | 5.36% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.15 | 0.17 | -0.03 | 0.14 | 0.27 | 0.00 | -0.77 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Other Expenses | 0.00 | 56.72M | 46.88M | 36.35M | 24.64M | 17.27M | 121.00K | 130.78K | 659.67K | 129.08K | 0.00 | 0.00 |
Operating Expenses | 16.90M | 73.27M | 63.33M | 66.32M | 37.44M | 27.23M | 18.61M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Cost & Expenses | 103.11M | 98.46M | 78.82M | 77.18M | 43.40M | 30.95M | 20.47M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Interest Income | 0.00 | 25.23M | 19.70M | 18.68M | 17.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 30.89M | 25.23M | 19.70M | 18.68M | 17.47M | 14.98M | 7.44M | 4.14M | 1.52M | 298.66K | 0.00 | 0.00 |
Depreciation & Amortization | 59.01M | 98.81M | 78.97M | 77.51M | 43.70M | 31.33M | 23.00M | 10.43M | 659.67K | 129.08K | 0.00 | 50.11K |
EBITDA | 111.64M | 96.49M | 84.00M | 53.00M | 50.82M | 40.20M | 17.35M | 2.48M | 569.53K | -224.46K | -45.34K | 0.00 |
EBITDA Ratio | 79.21% | 70.28% | 72.45% | 56.44% | 73.48% | 75.58% | 66.18% | 30.75% | 58.04% | -59.01% | 0.00% | 0.00% |
Operating Income | 37.94M | 38.83M | 37.12M | 16.55M | 27.33M | 22.24M | 7.35M | -2.21M | -1.52M | -652.21K | -45.34K | -50.11K |
Operating Income Ratio | 26.92% | 28.28% | 32.02% | 17.65% | 38.64% | 41.82% | 24.31% | -27.41% | -73.96% | -171.45% | 0.00% | 0.00% |
Total Other Income/Expenses | -16.20M | -18.83M | -18.78M | -30.77M | -17.47M | -7.68M | -9.96M | -6.33M | -2.13M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 21.73M | 20.00M | 18.34M | -2.50M | 9.59M | 14.56M | -87.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Income Before Tax Ratio | 15.42% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 25.23M | 20.42M | 18.11M | 17.83M | 1.07M | -49.00K | 4.27M | 1.52M | 597.33K | 0.00 | 50.11K |
Net Income | 20.61M | -5.23M | -2.07M | -20.61M | -8.24M | 13.49M | -38.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Net Income Ratio | 14.63% | -3.81% | -1.79% | -21.98% | -11.65% | 25.36% | -0.13% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
EPS | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
EPS Diluted | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
Weighted Avg Shares Out | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Weighted Avg Shares Out (Dil) | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Global Medical REIT (GMRE) Misses Q2 FFO and Revenue Estimates
Global Medical REIT Announces Second Quarter 2023 Financial Results
Global Medical REIT Inc. Announces Dates for Second Quarter Earnings Release and Webcast
I Am Buying These 8% Yielding REITs
Lock In A 9.5% Yield With Global Medical REIT
Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates
3 'Strong Buy' REITs At Steep Discounts
Global Medical REIT Inc. Board Declares 2023 Second Quarter Common and Preferred Dividends
It's The Perfect Time In The Interest Rate Cycle To Buy REITs
Global Medical REIT Inc. Releases Corporate Social Responsibility Report
Source: https://incomestatements.info
Category: Stock Reports